Bill · S. 297· Senate(119-S-297)
PSA Screening for HIM Act
- Introduced
- 1/29/2025
- Last activity
- 3/19/2026 — Committee on Health, Education, Labor, and Pensions. Hearings held.
- Sponsored by
- John Boozman
- Cosponsors
- - 0 - 6
- Introduced
- In Committee
What this bill would do
This bill, known as the "Prostate-Specific Antigen Screening for High-risk Insured Men Act," seeks to amend the Public Health Service Act. It would require group health plans and health insurance issuers to provide coverage for prostate cancer screenings without cost-sharing requirements. This coverage would specifically apply to men aged 40 and older who are at high risk, including African-American men and those with a family history. The bill defines a family history as having a first-degree relative with a diagnosis, development, or death related to prostate cancer, or a specific genetic alteration. These changes are intended to take effect for plan years beginning on or after January 1, 2025.
Yes· 3 of 9
Would Black Americans be better off under this?+7
The bill specifically addresses the higher risk of prostate cancer faced by African-American men through cost-free screenings.
Would men be better off under this?+7
The bill provides essential health benefits specifically for men at high risk of prostate cancer.
Does this make health care easier to get in general?+7
The bill increases healthcare access by requiring coverage for prostate cancer screenings without cost-sharing for high-risk men.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Elimination of Cost-Sharing for High-Risk Men: The bill requires insurance to cover prostate cancer screenings without imposing cost-sharing requirements for men aged 40 and over who are at high risk (Section 3(a)). This helps minimize barriers to screening for men who are at higher risk of developing the disease (Section 2(11)).
-
Improved Early Detection: By providing coverage for screenings without out-of-pocket costs, the bill aims to catch asymptomatic prostate cancer before it reaches a late stage (Section 2(11)). This is significant because early-stage survival rates are near 100 percent, whereas late-stage survival rates are only 37 percent (Section 2(3)).
-
Targeted Support for High-Risk Groups: The bill specifically addresses high-risk groups, such as African-American men, who have a disproportionately higher rate of prostate cancer and are more likely to die from it (Section 2(5), Section 2(6)). It also provides coverage for men with a family history of the disease (Section 3(a)(1)(E)).
Potential Negative Impacts for People
- No negative impacts or burdens are explicitly stated in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For African Americans+7Good For Men+7Good For Middle Aged+5Good For Seniors+5Good For Low Income Households+4Good For White Americans+3
- Healthcare
- Improves Healthcare Access+7Increases Affordable Care Act Support+5
- Social Issues And Justice
- Improves Racial Equity+6
- 3/19/2026
- Committee on Health, Education, Labor, and Pensions. Hearings held.
- 3/12/2025
- 1 Cosponsor added.
- 3/11/2025
- 1 Cosponsor added.
- 2/25/2025
- 3 Cosponsors added.
- 1/29/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 1 Cosponsor added.
- Introduced in Senate
Cory BookerDemocrat · New Jersey
Maria CantwellDemocrat · Washington
Christopher CoonsDemocrat · Delaware
Alex PadillaDemocrat · California
Jeanne ShaheenDemocrat · New Hampshire
Raphael WarnockDemocrat · Georgia